Mohamad Alkhouli, TCT 2022: Transcatheter edge-to-edge repair for patients with cardiogenic shock and mitral regurgitation, insights from the TVT registry
This study aimed to assess whether transcatheter edge-to-edge repair (TEER) positively impacts patients with cardiogenic shock and mitral regurgitation. In this touchCARDIO interview, we speak with Dr Mohamad Alkhouli (Mayo Clinic School of Medicine, Rochester, MN, USA) to discuss the TVT registry and the patient population who are the best candidates for TEER.
The abstract entitled ‘Transcatheter Edge-to-Edge Repair in Patients With Severe Mitral Regurgitation and Cardiogenic Shock: Insights From the TVT Registry’ was presented at the Transcatheter Cardiovascular Therapeutics (TCT) conference, 16 – 19, September 2022.
- What are the unmet needs in the treatment of cardiogenic shock with significant mitral regurgitation? (0:15)
- What is known about the impact of transcatheter edge-to-edge repair (TEER) on haemodynamics and clinical outcomes of patients with cardiogenic shock and mitral regurgitation? (1:06)
- Could you give us a brief overview of the TVT registry and its aims? (1:56)
- What have been the major insights from the registry regarding TEER in this treatment setting? (3:45)
- Which patients are the best candidates for TEER and in whom is it contraindicated? (5:46)
Disclosures: Mohamad Alkhouli has nothing to disclose in relation to this video interview.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Danielle Crosby.
Filmed as a highlight of TCT 2022
Access more content on Devices here
Share this Video
Related Videos In Devices
Gregg Stone, ACC 2023: Transcatheter edge-to-edge repair for functional mitral regurgitation in heart failure
Transcatheter edge-to-edge repair (TEER) is a minimally invasive procedure that can effectively treat functional mitral regurgitation in heart failure patients. Compared to traditional surgical approaches, TEER offers benefits such as reduced hospital stay, lower risk of bleeding and infection, and faster recovery time. Additionally, TEER has been found to improve symptoms and quality of life […]
Andrew Krahn: Heart Rhythm 2023 & HRX 2023 – The latest Innovations in arrhythmia care and technology
Dr Andrew Krahn, President, Heart Rhythm Society (HRS), discusses the upcoming Heart Rhythm 2023 meeting (May 19-21, 2023, New Orleans, LA, USA), and the HRX 2023 conference (September 21-23, 2023, in Seattle, WA, USA) hosted by the Heart Rhythm Society (HRS), a non-profit organization dedicated to improving the care of patients with heart rhythm disorders […]
Steven Messe, TCT 2022: Sentinel® cerebral protection system efficacy in reducing all stroke/disabling stroke, the PROTECTED-TAVR trial (a neurologist’s perspective)
The PROTECTED-TAVR trial studied the efficacy of using an embolic protection device (Sentinel® cerebral protection system) during transcatheter aortic valve replacement in reducing the incidence of stroke/disabling stroke. In this touchCARDIO interview, we speak with Dr Steven Messe (University of Pennsylvania, Philadelphia, PA, USA) to give a Neurologist’s perspective on the findings of the PROTECTED-TAVR […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!